The in vivo relationship between human tumor cells and interacting normal cells in their local environment is poorly understood. Here, using a uniquely developed in vitro co-culture system for human embryonic stem cells (hESCs), we examined the interactions between transformed and normal human stem cells. Co-culture of transformed-hESCs (t-hESCs) with normal hESCs led to enhanced self-renewal and niche independence in normal hESCs. Global gene expression analysis of normal hESCs after timed exposure to t-hESCs indicated a transition of the molecular network controlling the hESC state, which included epigenetic changes, towards neoplastic features. These included enhanced pluripotent marker expression and a differentiation blockade as major hallmark changes. Functional studies revealed a loss in normal terminal differentiation programs for both hematopoiesis and neural lineages after normal stem cell co-culture with transformed variants. This transmission of neoplastic properties from t-hESCs to normal hESCs was dependent on direct cell-cell contact. Our study indicates that normal human stem cells can co-opt neoplastic cancer stem cell properties, raising the possibility that assimilation of healthy cells towards neoplastic behavior maybe a contributing feature of sustained tumorigenesis in vivo.
Introduction
It has become increasingly evident that interactions between transformed cells and their normal cell microenvironment cooperatively regulate neoplastic progression (Joyce, 2005) . For example, communication between Rasor Src-transformed Madin Darby canine kidney epithelial cells and their surrounding normal counterparts facilitates basal extrusion of transformed cells from epithelial sheets to promote tumor progression and metastasis (Hogan et al., 2009; Kajita et al., 2010) . The interplay at the normal-transformed cell interface has also been examined in the Drosophila system in which wild-type Drosophila cells undergo apoptosis when situated next to mutant cells overexpressing DMYC, the homolog of the proto-oncogene myc (de la Cova et al., 2004; Moreno and Basler, 2004) . This suggests that cell competition leads to survival and proliferation of a dominant cell over a suboptimal phenotype that is normally viable in a homotypic environment (Moreno, 2008) . Although these studies establish a fundamental relationship between normal and transformed cells, very little is known about these interactions in human cancer stem cell (CSC) populations, believed to be the basis for sustained neoplastic progression (Wicha et al., 2006a; Rosen and Jordan, 2009) .
Therapies targeting the heterogeneous tumor environment, containing both normal and neoplastic cells are effective in the treatment of malignant tumors. However, identifying the key molecular events that facilitate interactions between transformed and normal cells or stem cells will be critical to further optimize these existing therapies, and more distinctly target neoplastic cells. In particular, it has not been determined whether these interactions directly contribute to normal stem cell transformation and the emergence of CSC populations. This would likely be complicated by the observed genetic and phenotypic heterogeneity in malignant CSCs, making it very difficult to understand the tumor cell of origin or to decipher disease etiology (Wicha et al., 2006b; Rosen and Jordan, 2009 ). In addition, normal comparative counterparts are largely unknown or unavailable for concurrent studies. To address these limitations, we have recently characterized variant human embryonic stem cells that have acquired features of neoplastic progression, including enhanced self-renewal, aberrant differentiation and elevated tumor-initiating cell capacity . Utilization of these transformed cells (t-hESCs), together with their normal counterparts, not only allows one to evaluate the early molecular events that govern transformation of human stem cells but also to directly assess the interactions between these two cell types. Here, we examined the complex relationships between transformed human stem cells and their normal cell counterparts in a novel in vitro system. Using co-culture of t-hESCs and normal hESCs, we demonstrate that normal human stem cells can coopt neoplastic CSC properties, raising the possibility that assimilation of healthy cells towards neoplastic behavior maybe a contributing feature of sustained tumorigenesis in vivo.
Results
Direct co-culture of hESCs and t-hESCs leads to enhanced expression of pluripotency markers To evaluate the relationship between normal hESCs and t-hESCs, we created and then co-cultured green-labeled normal hESC-green fluorescent protein (GFP) (hESCs) and red-labeled t-hESC dsRED (t-hESCs) cells at different ratios for 3-4 weeks, constituting 5 passages ( Figure 1a ).
Throughout this period, there was no evidence of heterogeneity within individual colonies (that is, individual colonies consisting of both hESC-GFP and t-hESC dsRED cells; Figures 1b-i) as cell-cell contact was restricted to the periphery of the hESC-t-hESC colony interface (Figures 1b-i; arrows) for all hESC:t-hESC ratios tested (Figures 1b-i).
To investigate the effect of co-culture on the phenotype of hESC and t-hESC cells, the expression of the pluripotent marker stage-specific embryonic antigen-3 (SSEA3) was evaluated by flow cytometry . Compared with hESCs cultured alone, co-culture of hESCs with t-hESCs resulted in a consistent increase in co-culture hESC (co-hESC) SSEA3 levels (Figures 2a  and c) . The resultant co-culture hESC SSEA3 frequency (91.0 ± 1.8%) was similar to values typically seen in transformed variants (Werbowetski-Ogilvie et al., 2009) (Figures 2b) . This observation was consistent and independent of passage (Supplementary Figure 1a) , whereas co-culture did not affect SSEA3 expression of t-hESCs (Figures 2b and c) . Importantly, the increase in co-culture hESC SSEA3 levels was evident for all hESC:t-hESC ratios tested (Figure 2d) , suggesting that the effect was not dependent on the dose or the number of t-hESCs present. The relative contribution of hESCs (% GFP cells) to co-culture did not significantly change over time (Figure 2e, and Supplementary Figures 1b and c) , indicating that both normal and transformed cells reach an equilibrium in co-culture over passage. Moreover, the relative mean fluorescent intensity of GFP and dsRED does not significantly change over time, demonstrating that GFP and dsRED expressions are not lost during co-culture and that we are not generating false positives by confusing hESC-GFP with t-hESCdsRED cells during analysis (Supplementary Figure 1d) . In addition, BrdU (5-bromo-2 0 -deoxyuridine) incor- Figure 1 Co-cultures of normal hESC GFP (hESCs) and transformed hESC dsRED (t-hESCs) cells. (a) Schematic depicting the co-culture model and phenotypic assessment following five passages. Normal hESC GFP cells and t-hESC dsRED cells were dissociated, mixed and re-plated in different ratios. Co-cultures were passed 5 times over 3-4 weeks, during which the pluripotent marker SSEA3 was used to assess the undifferentiated state. (b-i) Representative images of co-cultures 1 week after re-plating. Brightfield (b and f), normal hESC GFP (c and g), t-hESC dsRED (d and h) and merged images of co-culture (e and i). It must be noted that there are no heterogeneous colonies in co-culture. Cell-cell contact is limited to the hESC GFP:t-hESC dsRED colony interface (arrows). Scale bars: 250 mm.
Transmission of neoplastic properties to normal human stem cells TE Werbowetski-Ogilvie et al Figure 2 Co-culture of hESCs with t-hESCs leads to enhanced self-renewal properties and hdF niche loss. (a, b) Representative dot plots of SSEA3 levels in normal hESC and t-hESC pure cultures (left panels) and normal hESCs and t-hESCs from co-culture (right panels). (c) Quantification of SSEA3 levels from both pure hESC and t-hESC cultures (N ¼ 3) (black bars) and co-cultured hESCs and t-hESCs (N ¼ 6) (white bars) in the undifferentiated state. Data are representative of three independent experiments. (d) Quantification of SSEA3 levels in co-cultures from different initial plating density ratios of GFP:dsRED cells. It must be noted that co-hESC GFP SSEA3 levels increase regardless of initial plating density. (e) Relative contribution of hESC GFP and t-hESC dsRED cells to co-culture upon initial re-plating and following three passages in co-culture. (f-h) Immunocytochemical analysis of (f Figure 1e) ; however, there was an increase in the frequency of co-cultured hESCs in G2-M (Supplementary Figure 1f) , suggesting that a higher percentage of cells are entering mitosis. Co-cultured hESC proliferative rates may be increasing to sustain their presence amidst the more rapidly cycling transformed cells . Collectively, the elevated pluripotent marker expression combined with maintained levels of normal hESCs over time suggest that co-culture of normal hESCs and thESCs leads to enhanced self-renewal of normal cells, whereas transformed variants remained unchanged. These results provide the foundation for functional and molecular studies to examine the effects on coexisting normal and transformed human stem cells.
Normal hESCs exhibit loss of the hdF-supportive niche upon co-culture with t-hESCs We have previously shown that transformation of hESCs is related to the loss of the autologous hESCderived fibroblast-like (hdF)-supportive niche (Bendall et al., 2007) and is a property of hESC neoplastic transformation . To test whether elevated co-culture hESC SSEA3 levels are accompanied by a change in hESC-derived niche, we examined Oct4 and A2B5 levels in hESCs before and after co-culture. Oct4 is a core pluripotent transcription factor, and A2B5, a cell surface marker associated with neural precursors (Carpenter et al., 2001b) has been shown to be localized to the differentiated cells surrounding hESC colonies (Carpenter et al., 2001b) . Immunocytochemistry on hESCs before co-culture confirmed Oct4 restriction to the colonies (Figures 2f and h ) and A2B5 expression specifically to the differentiated hdF niche (Figures 2g and h ). To determine the specific contribution of niche cells to co-cultured hESCs, we compared A2B5 levels in co-cultured hESCs vs hESCs. Co-culture of normal hESCs with t-hESCs resulted in an 84% reduction of normal hdF cells (Figures 2i and j) , whereas the niche contribution remained negligible in t-hESCs (Figures 2i and j) . Interestingly, the small proportion of remaining hdFs from co-culture hESCs expresses insulin-like growth factor-1 receptor (Supplementary Figure 1g) , a property that is typically restricted to the pluripotent colonies (Bendall et al., 2007) . This suggests that the remaining co-cultured hESC hdFs are undergoing a phenotypic transformation and may no longer fulfill the definition of typical hESC-derived niche cells. Furthermore, re-introduction of hdF niche cells to t-hESCs over 1-3 passages did not result in any changes to the aberrant self-renewal, niche and differentiation properties (Supplementary Figure 2) previously documented for these variant lines (WerbowetskiOgilvie et al., 2009) , demonstrating that neoplastic features are not easily reverted. Taken together, these results suggest that in direct co-culture, neoplastic properties are transmitted to normal hESCs including enhanced self-renewal and loss of autologous hdFs, leading to niche independence.
Co-cultured hESCs exhibit a shift in molecular networks towards a neoplastic phenotype The phenotypic changes in co-cultured hESCs suggest that molecular properties may also be altered after exposure to transformed variants. This may be attributed to the acquisition of chromosomal abnormalities during co-culture, similar to t-hESCs (Damjanov and Andrews, 2007; Lensch and Ince, 2007; WerbowetskiOgilvie et al., 2009) . To evaluate the effect of direct coculture on DNA copy number variants in co-cultured hESCs, we conducted array comparative genomic hybridization (aCGH) analysis on hESCs before and after co-culture ( Figure 3a ). hESCs did not exhibit any chromosomal abnormalities, whereas t-hESCs displayed the 20q11.1-11.2 amplification previously identified for this variant cell line ( Figure 3a ) ). Similar to normal hESCs, the resulting cocultured hESCs did not exhibit any karyotypic abnormalities ( Figure 3a ), indicating that Mendelian changes or genome sequence variations are not responsible for the acquisition or selection of transformed properties in co-cultured hESCs. The lack of heritable gross Mendelian changes suggests that adoption of transformed features in co-cultured hESCs may be attributed to a shift in molecular networks vs genetic mutations. To evaluate the effect of co-culture on global gene expression, we conducted Affymetrix chip analysis (Affymetrix, Santa Clara, CA, USA) on normal hESCGFPs sorted after three passages of co-culture with t-hESCs and compared with both normal and t-hESCs cultured alone. Unbiased hierarchical clustering based on global gene expression revealed that co-cultured hESCs have not diverged significantly from hESC controls (Supplementary Figure 3a ). We next looked at differences in the expression of genes associated with specific biological properties. An examination of all biological categories revealed common significant changes in co-cultured hESCs and t-hESCs (Supplementary Figure 3b and Supplementary Table 1 ). In particular, transcripts associated with cell-to-cell signaling and interactions were among the most significantly dysregulated (Supplementary Figure 3b and Supplementary Table 1). As t-hESCs with elevated SSEA3 levels also exhibit enhanced cell growth and proliferation (WerbowetskiOgilvie et al., 2009), we also examined patterns of gene expression associated with cell-cycle regulation. Cocultured hESCs clustered with t-hESCs and not with normal hESC controls (Figure 3b, Supplementary Table  2 ). This was attributed to various dysregulated genes associated with all stages of the cell cycle and cell proliferation (Supplementary Table 2 ). This clustering of co-hESCs and t-hESCs based on cell-cycle properties is likely due to the loss of hdFs and heterogeneity in cohESCs previously defined for t-hESCs (WerbowetskiOgilvie et al., 2009). These results suggest that co-culture of hESCs with transformed variants alters various cellular properties including genes associated with cellTransmission of neoplastic properties to normal human stem cells TE Werbowetski-Ogilvie et al cell interactions and cell cycle in normal embryonic human stem cells.
Aberrant differentiation capacity represents a critical hallmark and functional measure for transformation of human CSCs (Wicha et al., 2006b ). In the case of hESCs, transformed variants are devoid of hematopoietic lineage capacity and exhibit a block in neural differentiation ( , Supplementary Tables  3-4) . Notably, of all the differentially expressed genes in t-hESCs and co-cultured hESCs, 12 have been shown to have specific roles in early hematopoiesis and/or neurogenesis that together form a group of genes essential for differentiation towards these lineages (Tsai et al., 1994; Hu et al., 1996; Kiefer et al., 1996; Kihm et al., 2002; Kitajima et al., 2002; Ivins et al., 2003; Murdoch et al., 2003; Besser, 2004; Snyder et (Tsai et al., 1994; Kitajima et al., 2002; Murdoch et al., 2003; Vijayaragavan et al., 2009) or are required (Azcoitia et al., 2005) for definitive hematopoiesis. Lefty2, which is upregulated in both t-hESCs and co-cultured hESCs vs hESCs cultured alone, is downregulated upon differentiation (Besser, 2004; Dvash et al., 2007) . Moreover, four of these genes (namely MAP4K1, Lefty1, ID4 and Meis1) were chosen for validation by quantitative PCR (qPCR) (Figures 3d and e) , and three were chosen for validation by ChIP (chromatin immunoprecipitation)-qPCR analysis of histone modifications (Supplementary Figure 4) . Interestingly, for the Lefty1 promoter locus, co-cultured hESCs exhibit methylation patterns similar to t-hESCs with higher levels of the 'activation' H3K4 mark and lower levels of the 'repressor' H3K27 mark (Supplementary Figure 4a) . In addition, methylation patterns for Lefty2 and HoxB2 in t-hESCs validate the Affymetrix data (Supplementary Figure 4b ), and suggest that global epigenetic changes may underlie the acquisition of neoplastic differentiation properties in hESCs. Collectively, these results demonstrate a shift in the molecular machinery of normal hESCs upon exposure to transformed variants, and reveal that a specific group of genes associated with differentiation may provide the molecular fingerprint predictive of a neoplastic block in differentiation. (Hu et al., 1996; Kiefer et al., 1996) . ERAF Erythroid-associated factor Present Present Regulates a-hemoglobin aggregation during erythroid development (Kihm et al., 2002) . LEFTY2 Left-right determination factor 2 þ 4.48 þ 4.41 Inhibit nodal signaling, expressed transiently in EBs, elevated in hESCs and downregulated upon differentiation (Dvash et al., 2007; Besser, 2004) ; overexpression promotes neuronal specification in EBs derived from hESCs (Smith et al., 2008 (Yu et al., 2005) ; regulates neural precursor cell proliferation and differentiation (Bedford et al., 2005) .
LEF1
Lymphoid enhancer-binding factor 1 Absent Absent Associated with Wnt3a canonical signaling that regulates hematopoietic and neural differentiation (Staal and Sen, 2008; Davidson et al., 2007) .
BMP5
Bone morphogenetic protein 5 Absent Absent BMP proteins have a prominent role in neurogenesis and have a role in hematopoiesis (Bragdon et al., 2011; Snyder et al., 2004) .
HoxB2
Homeo box B2 Absent Absent Is a direct target for regulation by PLZF in the CNS during development and deregulation and may also contribute to acute promyelocytic leukemia pathogenesis (Ivins et al., 2003) .
PTEN
Phosphatase and tensin homolog Absent Absent Required for HSC function; loss leads to myeloproliferative disease and leukemia (Zhang et al., 2006; Yilmaz et al., 2006) , lost in many malignant brain tumors (Huse and Holland, 2010) .
Abbreviations: CNS, central nervous system; co-hESCs, co-culture human embryonic stem cell; EB, embryoid body; HSC, hematopoietic stem cell; MMTV, mouse mammary tumor virus; PLZF, promyelocytic leukemia zinc finger; t-hESCs, transformed human embryonic stem cell. Genes were at least fourfold upregulated or downregulated relative to expression in pure hESC cultures. Genes that were present/absent in co-hESCs and t-hESCs vs pure hESCs were also included in this group. To functionally test this hypothesis, embryoid bodies (EBs) were formed from hESCs, t-hESCs and bulk co-cultures, and subjected to both hematopoietic and neural differentiation protocols. Compared with hESCs, co-cultured hESCs exhibited a 75% reduction in the frequency of hematopoietic cells indicated by the expression of the human pan-leukocyte marker CD45 (Figure 4a ). In contrast, t-hESCs did not exhibit a significant change in hematopoiesis and remained refractory to differentiation (Figure 4a ). We also investigated the transcript levels of receptors associated with the hematopoietic growth factors used in our differentiation protocols to determine whether cohESCs were capable of responding to appropriate hematopoietic signaling cues (Wang et al., 2004) (Supplementary Table 5 ). Hematopoietic growth factor receptor expression was similar in normal hESCs cultured alone, t-hESCs and co-cultured hESCs (Supplementary Table 5 ), suggesting that all three lines can respond to hematopoietic factors but are intrinsically incapable of mounting a hematopoietic differentiation program. Similarly, co-cultured hESCs also showed a significant decline in the frequency of cells undergoing neural differentiation (Supplementary Figure 5) . These results demonstrate that co-culture of normal hESCs with transformed variants leads to a substantial decline in normal cell differentiation, whereas transformed cells are unaffected by interaction with their normal counter- Table 1 ), indicate that co-cultured hESCs exhibit a terminal differentiation blockade, a critical feature associated with neoplastic transformation of human stem cells.
Transmission of neoplastic properties to normal hESCs from transformed variants is cell contact dependent
Our results indicate that co-culture of normal hESCs with t-hESCs results in co-cultured hESCs adopting transformation features including enhanced self-renewal, niche loss and decreased differentiation. To examine the mechanism of transmission, we cultured hESCs in the presence of conditioned media harvested from t-hESCs (Figures 4b-d) or Transwell co-culture of normal hESCs with t-hESCs to allow for physical separation (Figures 4e-h ). Compared with controls (50% hESC-conditioned media: 50% mouse embryonic fibroblast (MEF) media), hESCs exposed to 50% t-hESC-conditioned media exhibited no change in SSEA3 expression levels or the relative number of SSEA3 þ cells, demonstrating that self-renewal properties are not regulated by paracrine mechanisms (Figures 4b  and c) . As co-cultured hESCs exhibit a differentiation blockade (Figure 4a, Supplementary Figure 5 ), we also examined the effect of transformed conditioned media on hematopoietic differentiation. The expression of the hematopoietic marker CD45 remained constant in hESC EBs exposed to transformed conditioned media demonstrating that hematopoiesis is unaltered in this system (Figure 4d ). We similarly compared expression levels of the differentiation genes identified in Table 1 in co-cultured hESCs and t-hESCs relative to hESCs exposed to t-hESC-conditioned media (Tcm samples). All 12 genes represented in Table 1 are also differentially expressed in co-cultured hESCs and t-hESCs relative to Tcm samples ( Table 2 ), demonstrating that the molecular profile for these specific genes under Tcm conditions is similar to hESC controls. To further validate the mechanism of transmission, we also used Transwell inserts as a measure of paracrine effects (Figure 4e ). Similar to conditioned media experiments, co-culture of hESCs with t-hESCs separated by Transwell inserts had no effect on SSEA3 expression (Figure 4f) . Notably, A2B5 levels also remained constant in hESCs cultured with t-hESCs separated by Transwell inserts (Figure 4g ), demonstrating that the hdF niche is maintained and providing further evidence that the acquisition of neoplastic features is not attributed to paracrine mechanisms. BrdU incorporation on bulk cultures revealed that there is a small, nonsignificant increase in the frequency of hESCs in the S phase after exposure to t-hESCs in Transwell inserts (Figure 4h ), suggesting that paracrine effects may at least partially contribute to cell-cycle property changes in co-culture. Collectively, these results suggest that normal hESC adoption of transformed properties is dependent on direct cell-cell contact with transformed variants, and that both functional and molecular changes cannot be recapitulated by paracrine mechanisms.
Discussion
Interactions between tumor cells and their surrounding normal cell microenvironment cooperatively regulate neoplastic progression (Joyce, 2005) . For example, several studies have demonstrated that cancer cells can modify their microenvironment to display increased proliferation and support or enhance malignant epithelial transformation (Bhowmick et al., 2004b; Joyce, 2005; Orimo et al., 2005; Erez et al., 2010) . More recently, critical stroma-specific signaling has been shown to actually suppress solid tumor growth (Bhowmick et al., 2004a; Trimboli et al., 2009) . Although these studies establish a definitive role for transformednormal cell interactions in tumorigenesis, the majority of this work has been conducted in mouse models, and consequently, very little is known about how this type of communication may facilitate transformation of normal human cells or stem cells. By deconstructing the complex human tumor-normal stem cell interactions using unique in vitro co-culture of normal hESC and their transformed counterparts representing CSCs, we propose (as illustrated in Figure 5 ) that transformed human stem cells transmit neoplastic properties to their normal counterparts and that these events are not attributed to Mendelian changes. The specific mode of cell-cell communication still remains to be determined. For example, the role of tight junctions or pseudopodial extensions in the transfer of specific neoplastic properties from transformed to normal hESCs is unknown. Recently, it has Abbreviations: CNS, central nervous system; co-hESCs, co-culture human embryonic stem cell; EB, embryoid body; MMTV, mouse mammary tumor virus; t-hESCs, transformed human embryonic stem cell. Genes were at least fourfold upregulated or downregulated relative to expression in Tcm samples. Genes that were present/absent in co-hESCs and t-hESCs vs Tcm samples were also included.
been shown that microvesicle- (Yuan et al., 2009) or exosome-mediated transfer (Valadi et al., 2007) of mRNA and micro-RNA facilitate exchange of material between different cell types. Although microvesicle transfer of mRNA and micro-RNA has been demonstrated for embryonic stem cells (Yuan et al., 2009) , this mechanism does not seem to be responsible for the specific changes in pluripotency and differentiation markers seen here (data not shown). It is well documented that cytokines, chemokines and growth factors mediate cross-talk between tumor cells and their microenvironment to facilitate malignant progression (Raman et al., 2007; Mishra et al., 2011 ). Our results demonstrate that paracrine mechanisms contribute to the enhancement of co-culture hESC cell cycle; however, both niche loss and blocked differentiation are exclusive to direct co-culture further demonstrating the importance of the transformed-normal cell interface in governing these effects. Moreover, dysregulation of specific neural and hematopoietic genes is also restricted to the direct co-culture system, providing a molecular fingerprint for aberrant differentiation and potential targets important for cell-cell-mediated early transformation of human stem cells. This does not rule out the possibility that paracrine mechanisms dictate other aspects of neoplastic transformation such as growth factor independence and enhanced tumorinitiating capacity, features known to be associated with t-hESCs (Werbowetski-Ogilvie et al., 2009), but not specifically evaluated in this study. The molecular data presented here provide the foundation for future mechanistic studies that include an investigation of cell signaling pathways involved in the acquisition of neoplastic properties in hESCs and a full-scale proteomics analysis to identify new 'markers' that are unique to t-hESCs. Furthermore, the methylation pattern changes on the specific differentiation gene loci warrant ChIP-on-chip studies to define the global epigenetic modifications that may underlie tumorigenic progression of hESCs. These and other large-scale studies are currently underway in our laboratory.
Co-culture of normal and transformed human stem cells serves as a useful in vitro surrogate for tumor-host cell interactions and can be used to explore the onset of transformation in human stem cells. Although not all t-hESC features previously defined (WerbowetskiOgilvie et al., 2009) were examined here (that is, teratoma formation), our current study builds on this previous work that did not delineate how hESCs acquire neoplastic features or link the functional changes to transcripts that may be responsible for these aberrant properties (Werbowetski-Ogilvie et al., 2009). It has been recently shown that the hESC microenvironment is involved in tumorigenesis of aggressive melanoma cells (Postovit et al., 2008) . This study supports a role for hESCs in regulating oncogenesis; however, the results may be cell context dependent. Our current study demonstrates that the presence of CSCs leads to a loss of the niche concomitant with blocked differentiation in favor of a self-renewal program in the co-culture hESC system we define. This mechanism of direct transmission of neoplastic properties from transformed to normal human stem cells may be responsible for the loss of heterogeneity evident in all transformed pluripotent stem cell variants (WerbowetskiOgilvie et al., 2009). Moreover, niche loss may contribute to the variable differentiation propensity typically observed among hESC lines and t-hESCs previously documented but not functionally characterized (Baker et al., 2007) to date. Our model provides a distinct advantage over other human CSC model systems in which only retrospective analysis of neoplastic cell evolution is possible. Assimilation of healthy cells towards neoplastic features likely contributes to the emergence of transformed variants in vitro and potentially sustained tumorigenesis in vivo. On the basis of our results, these concepts should be further explored as an overarching mechanism contributing to the evolution of human CSC phenotypes in vivo.
Materials and methods
hESC and t-hESC cell culture Normal and transformed H9 and H1 hESC lines were maintained as described previously . In brief, cells were cultured on Matrigel (BD Biosciences, Mississauga, ON, Canada) in MEF-conditioned media (MEF-CM) supplemented with 8 ng/ml basic fibroblast growth factor. For co-cultures, H1 and t-hESC (H9 v1) cells were transduced with viral supernatant produced using the ViraPower Lentiviral Expression System (Invitrogen, Burlington, ON, Canada) as described previously (Stewart et al., 2006) . hESC-GFP (H1) and t-hESC dsRED (H9 v1) cells were expanded and sorted based on the frequency of the reporters eGFP and dsRED, respectively (Stewart et al., 2006) . For direct co-culture, hESC-GFP cells and t-hESC-dsRED cells were dissociated and re-plated in different ratios per well contribution. Co-cultures and pure control wells were passed 1:3 every 5-6 days for 3-5 passages before analysis.
For conditioned media experiments, hESCs were maintained in MEF-CM supplemented with basic fibroblast growth factor or 50% MEF-CM: 50% filtered hESC-conditioned media or 50% MEF-CM: 50% filtered t-hESC-conditioned media for 3-4 passages. Fresh conditioned media from hESCs Transmission of neoplastic properties to normal human stem cells TE Werbowetski-Ogilvie et al and t-hESCs were aspirated, spun at 1500 r.p.m. for 10 min to remove cell debris and filtered using a 0.22-mm filter before feeding hESCs daily. For Transwell insert experiments, a pore size of 0.4 mm was used to inhibit cell migration through the membrane. hESCs and either hESCs or t-hESCs were plated into Matrigel-coated bottom wells and top inserts, respectively. Transwell inserts and cells in the bottom wells were dissociated, gently scraped and passed 1:3 every 5-6 days for 3-4 passages before analysis.
EB formation, hematopoietic and neural precursor differentiation Embryoid bodies were formed from both direct co-culture and hESCs treated with conditioned media as described previously Wang et al., 2004; WerbowetskiOgilvie et al., 2009) . Cells were transferred to low-attachment 6-well plates in the differentiation medium consisting of 80% knockout Dulbecco's modified Eagle's medium (Gibco, Burlington, ON, Canada), 20% non-heat inactivated fetal calf serum (HiClone, Fisher Scientific, Ottawa, ON, Canada), 1% nonessential amino acids, 1 mM L-glutamine and 0.1 mM b-mercaptoethanol. Culture media were replaced on day 1 with EB media supplemented with hematopoietic growth factors as follows: 50 ng/ml granulocyte colony stimulating factor (hG-CSF) (Amgen, Thousand Oaks, CA, USA), 300 ng/ml stem cell factor (hSCF) (Amgen), 10 ng/ml interleukin-3 (hIL-3) (R&D Systems, Minneapolis, MN, USA), 10 ng/ml hIL-6 (R&D Systems), 25 ng/ml bone morphogenetic protein-4 (hBMP-4) (R&D Systems) and 300 ng/ml hFlt-3 l (R&D Systems). EBs were maintained for 16 days, and the medium was changed every 4 days. For neural precursor differentiation, EBs cultured in the EB medium alone for 4 days were transferred to 12-well plates coated with poly-L-lysine/fibronectin in neural proliferation medium consisting of Dulbecco's modified Eagle's medium/ F12 with B27 and N2 supplements (Gibco), 10 ng/ml basic fibroblast growth factor, 10 ng/ml human epidermal growth factor, 1 ng/ml human platelet-derived growth factor-AA (R&D Systems) and 1 ng/ml human insulin-like growth factor-1 (hIGF-1) (R&D systems) (Carpenter et al., 2001a) . Cultures were expanded over 4 days.
hdFs preparation and co-culture with t-hESC dsRED cells hdFs were prepared as described previously (Stewart et al., 2006) . Confluent hdFs were passed, mixed with t-hESCdsRED cells (t-hESC-dsRED cells alone were used as controls) and re-plated. Both control and co-cultured wells were passed 1:6 every 5 days for 1-3 passages.
Flow cytometry
Single cell suspensions of bulk direct, Transwell insert co-cultured cells or conditioned media-treated cells were dissociated with collagenase IV at 37 1C. EBs were dissociated with 0.4 Units/ml collagenase B (Roche Diagnostics, Laval, QC, Canada) for 2 h in a 37 1C incubator, followed by treatment with cell-dissociation buffer (Invitrogen) for 10 min at 37 1C. The following primary and secondary antibodies were used for flow-cytometry analysis: rat anti-SSEA3 (Developmental Studies Hybridoma Bank, Iowa City, IA, USA), mouse anti-A2B5 (R&D Systems), goat anti-rat IgM Alexa 647 (Invitrogen) and goat anti-mouse IgM Alexa 647 (Invitrogen). We used 7-amino actinomycin (Immunotech, Marseille, France) to eliminate dead cells. Surface marker expression was analyzed using a FACSCalibur (BD Biosciences) and FlowJo software (Tree Star, Ashland, OR, USA). For hematopoietic differentiation, EBs were stained at day 16 with the fluorochrome-conjugated antibody CD45-APC (Miltenyi, Auburn, CA, USA) and the corresponding isotype control. EBs in the neural proliferation medium were trypsinized after 4 days in culture and stained with the cell surface marker A2B5 (R&D Systems). Cells were visualized using goat anti-mouse IgM m chain Alexa 647 (Molecular Probes, Invitrogen).
Immunocytochemical analysis
Normal hESCs cultured on Matrigel-coated 4-well chamber slides (Lab-Tek, Fisher Scientific) were rinsed three times before fixation with 4% paraformaldehyde in phosphatebuffered saline for 20 min and then permeablized with 0.5% saponin in phosphate-buffered saline containing 1% bovine serum albumin. Cells were blocked with 10% normal rabbit serum for 30 min at room temperature. The following primary and secondary antibodies were used: mouse anti-A2B5 (1:150) (R&D Systems, Santa Cruz, CA, USA), goat anti-Oct3/4 (N19) (1:50) (Santa Cruz Biotechnology), rabbit anti-mouse-488, IgM (m-chain) (Invitrogen) and rabbit anti-goat-594, IgG (Invitrogen). Primaries were incubated at 4 1C for 24 h, and secondary antibodies were incubated at room temperature for 1 h. Chamber slides counterstained using Vectashield Mounting Medium with DAPI (Vector Labs, Burlington, ON, Canada) and examined using an Olympus IX51 microscope (Olympus, Markham, ON, Canada). Fluorescence images were captured using a Photometrics Cool Snap HQ2 (Photometrics, Tucson, AZ, USA) camera using Image-Pro 3DA version 6.0 (MediaCybernetics, Bethesda, MD, USA).
Cell sorting and preparation for Affymetrix and aCGH analysis Pure hESC-GFP and t-hESC dsRED cells, as well as co-hESC-GFP and t-hESC dsRED cells were dissociated after four passages and stained with the cell surface marker A2B5 (R&D Systems). Cells were visualized using Alexa Fluor 647 goat anti-mouse IgM m chain (Molecular Probes, Invitrogen). Cells were sorted based on GFP and/or A2B5 expression using a FACS Aria sorter (BD Biosciences). Collected GFP, dsRED, GFP/A2B5 þ and GFP/A2B5À cells were centrifuged and prepared for RNA and DNA extraction for aCGH analysis.
Affymetrix analysis
Total RNA was isolated from sorted t-hESC dsRED, hESC-GFP, co-hESC-GFP, GFP/A2B5 þ and GFP/A2B5À cells using the AllPrep DNA/RNA Mini Kit (Qiagen, Toronto, ON, Canada) according to the manufacturer's instructions. RNA amplification, GeneChip 3 0 oligonucleotide microarray hybridization and processing were performed by the London Regional Genomics Institute (Robarts Research Institute, London, ON, Canada) according to the manufacturer's protocols (Affymetrix). For each sample, 10 mg of cRNA was labeled and hybridized to the Affymetrix HG-U133 Plus 2.0 chips. Expression signals were scanned on an Affymetrix GeneChip Scanner, and data extraction was performed using Affymetrix AGCC software. Data normalization and analysis were performed using Dchip software (Li and Wong, 2001 ). Hierarchical clustering using Pearson's correlation coefficients was performed on the normalized data. Differentially upregulated genes were analyzed using Gene Spring (Agilent Technologies, Mississauga, ON, Canada) and Ingenuity (Redwood City, CA, USA) software.
Quantitative PCR
Total RNA was extracted from sorted pure hESC-GFPs, t-hESC dsREDs and co-cultured hESC-GFPs using the AllPrep DNA/RNA Mini Kit (Qiagen) according to the manufacturer's guidelines. RNA was DNAse treated for 45 min at 37 1C in DNAse I RNAse-free (Invitrogen). First-strand cDNA was synthesized using the First-Strand cDNA Synthesis Kit (Amersham Biosciences, GE Healthcare, Baie D'Urfe, QC, Canada). PCR using a template generated without reverse transcriptase or PCR in the absence of templates was used as a negative control. The following PCR conditions were used: 50 1C for 2 min, 95 1C for 2 min and 40 cycles of 95 1C for 15 s, 60 1C for 30 s. qPCR was conducted using Platinum SYBR Green qPCR SuperMix-UDG (Stratagene, Agilent Technologies) on a Mx3000P (Stratagene) QPCR system according to the manufacturer's guidelines (Stratagene). All values were normalized to the GAPDH housekeeping gene.
Gene
Sequence Product (bp)
MAP4K1 5 Array comparative genomic hybridization hESCs, t-hESCs and co-hESCs were prepared for aCGH analysis as described previously . In brief, for each specimen and reference sample, 1 mg of DNA was measured by concentration/volume. Sex mismatch forward-reverse experiments were used to provide a one copy gain/loss of the X chromosome for reference within the experiment. Hybridization mixtures were pipetted onto a Constitutional Chip 4.0 (Perkin-Elmer, Waltham, MA, USA) slide containing >5000 BAC clones spanning the genome at B0.5-Mb intervals spotted in duplicate on glass slides, covered with a 22 Â 60 mm 2 cover slip, sealed in a hybridization chamber (Corning, Fisher Scientific) and hybridized at 37 1C. Arrays were then scanned on a ScanArray Gx Plus microarray scanner (Perkin-Elmer) or the Genepix 4000B scanner (Molecular Devices, Sunnyvale, CA, USA) and analyzed with SpectralWare 2.2.4 (Perkin-Elmer).
ChIP analysis hESC, t-hESC and co-hESC subsets were sorted and crosslinked using 1% formaldehyde. Chromatin was digested in buffer containing 0.1% SDS to obtain fragments of B500 bp length. Sonicated DNA was subjected to immunoprecipitation using anti-trimethyl H3K4 (Abcam), anti-trimethyl-H3K27 (Abcam, Cambridge, MA, USA) anti rabbit IgG and anti mouse IgG antibodies. Immunoprecipitated DNA was further reverse cross-linked, purified and subjected to qPCR analysis using Cyber Green dye. The sequences of the primers used for amplification were: Lefty1: F-5 0 ATCCTTCCCGCCCTTC CTTTATGA3 0 ,R5 0 AGTCCTGCTAGCCAGCTGCTTAAA3 
Cell-cycle analysis
For cell-cycle analysis, hESCs cultured in either 50% hESC-or t-hESC-conditioned media after 3 passages were exposed to 10 mM BrdU for 1 h before cell harvest. Single cells suspensions were then fixed in EtOH 70% after phosphate-buffered saline/ fetal bovine serum 3% wash. Detailed protocols are described in the study by Stewart et al. (2006) .
Statistical analysis
All tests were performed using Prism 5 software (GraphPad Software, La Jolla, CA, USA). Descriptive statistics were used to determine significant differences including mean and s.e.m. along with one-way ANOVAs (analyses of variance), independent sample two-tailed t-tests and Tukey's test for multiple comparisons. P-values o0.05 were considered significant.
